Use of antioxidant supplements in the treatment of human oral leukoplakia review of the literature and current studies

This publication has 78 references indexed in Scilit:

• Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin
  New England Journal of Medicine, 1995
• The use of 13-cis-retinoic acid in the treatment of oral leukoplakia: Short-term observations
  Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1995
• A randomised controlled trial to test equivalence between retinyl palmitate and beta carotene for vitamin A deficiency.
  BMJ, 1993
• A Prospective Study of the Intake of Vitamins C, E, and A and the Risk of Breast Cancer
  New England Journal of Medicine, 1993
• Effect of Vitamin E Supplementation on Immune Responsiveness of the Aged^a
  Annals of the New York Academy of Sciences, 1989
• Normal serum response to oral beta-carotene in humans.
  Journal of the American College of Nutrition, 1989
• Regression of experimental cancer by oral administration of combined α‐tocopherol and β‐carotene
  Nutrition and Cancer, 1989
• 13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia
  New England Journal of Medicine, 1986
• Beta carotene is associated with the regression of hamster buccal pouch carcinoma and the induction of tumor necrosis factor in macrophages
  Biochemical and Biophysical Research Communications, 1986
• Studies in Oral Leukoplakias III. Effects of Vitamin a Comparing Clinical, Histopathologic, Cytologic, and Hematologic Responses
  Acta Odontologica Scandinavica, 1963